|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0022341,
umls-concept:C0030705,
umls-concept:C0205179,
umls-concept:C0282460,
umls-concept:C0684249,
umls-concept:C0762659,
umls-concept:C1515417,
umls-concept:C1518578,
umls-concept:C1705493,
umls-concept:C2603343
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2006-5-9
|
|
pubmed:abstractText |
Amrubicin is a novel 9-aminoanthracycline. This multicenter phase II study was conducted to evaluate the efficacy and safety of amrubicin in patients with non-small-cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0167-6997
|
|
pubmed:author |
pubmed-author:AriyoshiYutakaY,
pubmed-author:IsobeTakeshiT,
pubmed-author:KameiTadashiT,
pubmed-author:KatakamiNobuyukiN,
pubmed-author:KawakamiAkiraA,
pubmed-author:KudohShinzohS,
pubmed-author:NakanishiYoichiY,
pubmed-author:SawaToshiyukiT,
pubmed-author:SugiuraTakahikoT,
pubmed-author:TakadaMinoruM,
pubmed-author:TohdaYujiY,
pubmed-author:YamamotoHidehikoH,
pubmed-author:YanaTakashiT,
pubmed-author:YokotaSoichiroS
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
151-8
|
|
pubmed:meshHeading |
pubmed-meshheading:16502350-Adult,
pubmed-meshheading:16502350-Aged,
pubmed-meshheading:16502350-Anthracyclines,
pubmed-meshheading:16502350-Antineoplastic Agents,
pubmed-meshheading:16502350-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:16502350-Drug Administration Schedule,
pubmed-meshheading:16502350-Female,
pubmed-meshheading:16502350-Humans,
pubmed-meshheading:16502350-Japan,
pubmed-meshheading:16502350-Lung Neoplasms,
pubmed-meshheading:16502350-Male,
pubmed-meshheading:16502350-Middle Aged,
pubmed-meshheading:16502350-Neoplasm Staging,
pubmed-meshheading:16502350-Survival Analysis
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial.
|
|
pubmed:affiliation |
Division of Respiratory Medicine, Gifu Municipal Hospital.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
